Allurion Technologies (ALUR) Change in Receivables (2022 - 2026)
Allurion Technologies (ALUR) posted Change in Receivables of -$365000.0 for Q1 2026, down 126.32% on a QoQ basis from $1.4 million in Q4 2025, and down 141.34% year-over-year from $883000.0 in Q1 2025.
Allurion Technologies (ALUR) Change in Receivables (2022 - 2026) Analysis & Trends
Allurion Technologies' Change in Receivables history runs 5 years deep, the most recent figure standing at -$365000.0 for Q1 2026.
- Quarterly Change in Receivables fell 141.34% year-over-year to -$365000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 67.42% YoY) and the FY2025 annual result came in at -$844000.0, up 90.6% from the prior year.
- Change in Receivables was -$365000.0 for Q1 2026 at Allurion Technologies, down from $1.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $9.0 million in Q4 2022 and bottomed at -$2.8 million in Q3 2024.
- A 5-year average of $120666.7 and a median of -$865000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 185.98% — and 2024, when it plunged 491.8%.
- Allurion Technologies' Change in Receivables stood at $9.0 million in 2022, then plunged by 128.52% to -$2.6 million in 2023, then soared by 30.68% to -$1.8 million in 2024, then soared by 178.01% to $1.4 million in 2025, then sank by 126.32% to -$365000.0 in 2026.
- Business Quant data shows ALUR's Change in Receivables at -$365000.0 in Q1 2026, $1.4 million in Q4 2025, and -$865000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -365,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -365,000.00 |
| Mar 31, 2026 | -365,000.00 |
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | -865,000.00 |
| Sep 30, 2025 | -865,000.00 |
| Jun 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | 883,000.00 |
| Mar 31, 2025 | 883,000.00 |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | -2.79 Mn |
| Sep 30, 2024 | -2.79 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Mar 31, 2024 | -1.67 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Dec 31, 2023 | -2.57 Mn |